Biochemical characterization of USP7 reveals post-translational modification sites and structural requirements for substrate processing and subcellular localization.
Open accessAbstract
Ubiquitin specific protease 7 (USP7) belongs to the family of deubiquitinating enzymes. Among other functions, USP7 is involved in the regulation of stress response pathways, epigenetic silencing and the progress of infections by DNA viruses. USP7 is a 130‐kDa protein with a cysteine peptidase core, N‐ and C‐terminal domains required for protein–protein interactions. In the present study, recombinant USP7 full length, along with several variants corresponding to domain deletions, were expressed in different hosts in order to analyze post‐translational modifications, oligomerization state, enzymatic properties and subcellular localization patterns of the enzyme. USP7 is phosphorylated at S18 and S963, and ubiquitinated at K869 in mammalian cells. In in vitro activity assays, N‐ and C‐terminal truncations affected the catalytic efficiency of the enzyme different. Both the protease core alone and in combination with the N‐terminal domain are over 100‐fold less active than the full length enzyme, whereas a construct including the C‐terminal region displays a rather small decrease in catalytic efficiency. Limited proteolysis experiments revealed that USP7 variants containing the C‐terminal domain interact more tightly with ubiquitin. Besides playing an important role in substrate recognition and processing, this region might be involved in enzyme dimerization. USP7 constructs lacking the N‐terminal domain failed to localize in the cell nucleus, but no nuclear localization signal could be mapped within the enzyme's first 70 amino acids. Instead, the tumor necrosis factor receptor associated factor‐like region (amino acids 70–205) was sufficient to achieve the nuclear localization of the enzyme, suggesting that interaction partners might be required for USP7 nuclear import.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
USP7 specifically cleaves ubiquitin and is unable to cleave other ubiquitin-like modifiers including SUMO and Nedd8.
“USP7 specifically cleaves ubiquitin and is unable to cleave other ubiquitin-like modifiers including SUMO and Nedd8 (Fernandez-Montalvan et al., 2007).”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Fernandez-Montalvan et al., 2007
Truncation of amino acids 1-207 of USP7 abolishes its ability to enter the nucleus.
“Thus, truncation of amino acids 1–207 abolishes its ability to enter the nucleus.”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Fernandez-Montalvan et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 56 · Cited by 96
- Authors
- Fernández‐Montalván, A., Bouwmeester, T., Joberty, G., Mader, R., Mahnke, M., Pierrat, B., Schlaeppi, J., Worpenberg, S., & Gerhartz, B.
- Affiliations
- Novartis (Switzerland) (CH)
- Novartis Institutes for BioMedical Research (CH)
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2007-07-25
- Volume
- 274
- Issue
- 16
- Pages
- 4256-4270
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- OpenAlex
- W1591200005
- Cited by
- 96
- References
- 56
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 4 · 2022: 5 · 2021: 5 · 2020: 7 · 2019: 8 · 2018: 3 · 2017: 4 · 2016: 6 · 2015: 5 · 2014: 5 · 2013: 7 · 2012: 6
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- FEBS Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Physical Sciences › Materials Science › Materials Chemistry › Enzyme Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- USP7, deubiquitinase, post-translational modification, phosphorylation, ubiquitination, catalytic efficiency, enzyme dimerization, ubiquitin binding, nuclear localization, subcellular localization, stress response, DNA virus infection
- MeSH terms
- Ubiquitin-Specific Peptidase 7, Amino Acid Sequence, Binding Sites, Cell Line, Cell Nucleus, Chromatography, Gel, Cytosol, HeLa Cells, Humans, Kinetics, Molecular Sequence Data, Molecular Weight, Mutation, Protein Processing, Post-Translational, Recombinant Fusion Proteins, Mass Spectrometry, Substrate Specificity, Transfection, Immunoblotting, Microscopy, Confocal, Dimerization, Catalytic Domain, Protein Transport, Ubiquitin Thiolesterase, Cell Line, Tumor, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review